CAREY ROBERT MICHAEL 4
4 · TAYLOR DEVICES, INC. · Filed Apr 20, 2026
Research Summary
AI-generated summary of this filing
Taylor Devices (TAYD) Director Carey Robert Michael Receives 7,000-Share Award
What Happened
- Carey Robert Michael, a director of Taylor Devices, Inc. (TAYD), reported a derivative award transaction on April 18, 2026. The Form 4 shows 7,000 derivative shares associated with a grant/award (transaction code A) recorded at $0.00 and marked as disposed; no cash was reported in the filing. This is an award/compensation-style transaction rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-04-18; reported on Form 4 filed 2026-04-20 (timely filing).
- Transaction type/code: A (grant/award or other acquisition) involving derivative securities; price reported $0.00.
- Quantity: 7,000 derivative shares (reported as disposed in the filing).
- Shares owned after transaction: Not specified in the information provided in this summary (check the full Form 4 for holdings column).
- Notable footnotes: Filing does not indicate a 10b5‑1 plan, tax withholding, or immediate open‑market sale; “disposed” can reflect settlement, conversion, cancellation, or reporting mechanics — the filing gives no further detail.
Context
- Derivative awards often represent restricted stock units (RSUs), option exercises, or other compensation-related instruments; a $0.00 price typically indicates a grant or conversion rather than a purchase. Because this is an award/compensation entry and not a purchase of stock, it should not be read as a straightforward bullish insider purchase. For confirmation or more detail (e.g., whether the award converted to shares, was immediately sold, or was used to cover taxes), review the complete Form 4 text or contact the company’s filings.
Insider Transaction Report
Form 4
CAREY ROBERT MICHAEL
Director
Transactions
- Award
Stock Option (Right to Buy)
2026-04-18−7,000→ 7,000 totalExercise: $56.43From: 2026-04-18Exp: 2036-04-18→ Common Stock (7,000 underlying)
Signature
Robert M. Carey|2026-04-20